bioAffinity Technologies shows asthma therapy matching technology Mar 3, 2026 08:31AM
bioAffinity Technologies starts lung cancer test validation study Feb 25, 2026 08:31AM
bioAffinity's CyPath Lung test helps avoid biopsy in elderly patient case Feb 19, 2026 11:01AM
bioAffinity Technologies, Inc. (BIAF) Misses Q3 EPS by 465c Nov 14, 2025 05:00PM
bioAffinity Technologies reports 111% jump in october lung test volume Nov 5, 2025 08:00AM


Oct 28, 2025 08:03AM bioAffinity Technologies receives Australian patent acceptance
Oct 16, 2025 08:02AM bioAffinity Technologies receives US patent allowance for lung cancer test
Oct 9, 2025 01:00PM bioAffinity Technologies closes $1.8 million stock offering
Oct 8, 2025 04:16PM bioAffinity Technologies raises $1.8 million in registered direct offering
Oct 8, 2025 03:47PM bioAffinity Technologies raises $1.8 million in registered direct offering
Oct 7, 2025 08:05AM bioAffinity reports 95% quarterly jump in lung cancer test sales
Sep 26, 2025 08:05AM bioAffinity shares case studies showing CyPath Lung test detected stage 1A cancer
Sep 15, 2025 06:07AM bioAffinity (BIAF) files for 32.5M share offering by selling stockholders
Aug 29, 2025 04:19PM bioAffinity (BIAF) files for 12.61M share offering by selling stockholders
Aug 14, 2025 04:38PM bioAffinity Technologies, Inc. (BIAF) Misses Q2 EPS by 7c
Jul 22, 2025 09:02AM bioAffinity Technologies receives Canadian patent for lung cancer test
Jul 15, 2025 09:02AM bioAffinity Technologies receives China patent for lung cancer diagnostic
Jun 24, 2025 09:05AM bioAffinity (BIAF) receives patent grant from CNIPA
May 28, 2025 09:01AM bioAffinity (BIAF) Announces New U.S. Patent for Novel Broad Spectrum Cancer Therapeutics
May 20, 2025 09:02AM bioAffinity (BIAF) Technologies Appoints Dr. Gordon Downie, MD, PhD, as Chief Medical Officer
May 15, 2025 05:48PM bioAffinity Technologies, Inc. (BIAF) Tops Q1 EPS by 1c
May 7, 2025 01:00PM bioAffinity (BIAF) Closes $3.25M Offering
May 6, 2025 09:26AM bioAffinity (BIAF) Prices $3.25M Share Offering at $0.32/sh
Apr 17, 2025 09:19AM bioAffinity (BIAF) Increases Efficiency of CyPath Lung Test by Boosting Data Acquisition Throughput by 50% and Reducing Unit Cost
Apr 17, 2025 09:00AM ASP Isotopes and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Mar 31, 2025 09:28AM bioAffinity (BIAF) Reports Record $9.4M Revenue for 2024
Mar 28, 2025 09:00AM bioAffinity Technologies and Can-Fite BioPharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Mar 6, 2025 08:03AM bioAffinity (BIAF) Announces Targeted Actions to Cut $4M in Costs
Jan 22, 2025 08:01AM bioAffinity (BIAF) Announces Acceptance of Patent Application for Early-Stage Lung Cancer Diagnostic
Jan 10, 2025 09:00AM Enlivex Therapeutics and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Nov 4, 2024 08:02AM bioAffinity (BIAF) Appoints William Bauta as Chief Science Officer
Oct 30, 2024 08:02AM bioAffinity (BIAF) receives Japanese Patent for CyPath Lung
Oct 18, 2024 12:45PM bioAffinity (BIAF) Prices 2.05M Share Offering at $1.30/sh
Oct 16, 2024 08:04AM bioAffinity's (BIAF) CyPath Lung Cancer Test Supported by Newly Published Flow Cytometry Guidelines
Oct 10, 2024 08:02AM bioAffinity (BIAF) Names J. Michael Edwards as Chief Financial Officer
Oct 9, 2024 08:03AM bioAffinity (BIAF) Awarded U.S. Federal Supply Schedule Contract for CyPath Lung Test
Aug 2, 2024 09:27AM bioAffinity (BIAF) Announces $1.75M Offering at $1.50/sh
Jul 12, 2024 09:35AM Biotricity and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Jul 9, 2024 08:08AM bioAffinity (BIAF) Reports 217% Sales Growth in Second Quarter 2024 for CyPath Lung
Jul 5, 2024 09:00AM BioVie and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV